Harold Gilbert

by Gilbert, Peter
Published 2003

Thermometers

by Gilbert, Peter
Published 1955

School Phobia

by Gilbert, Peter
Published 1960

SOME DESIGN ISSUES IN PHASE 2B VERSUS PHASE 3 PREVENTION TRIALS FOR TESTING EFFICACY OF PRODUCTS OR CONCEPTS

by Gilbert, Peter B.
Published 2010

Ongoing Vaccine and Monoclonal Antibody HIV Prevention Efficacy Trials and Considerations for Sequel Efficacy Trial Designs

by Gilbert, Peter B.
Published in Stat Commun Infect Dis (2019)

Evaluating Immune Correlates in HIV Type 1 Vaccine Efficacy Trials: What RV144 May Provide

by Rolland, Morgane, Gilbert, Peter
Published 2012

Statistical identifiability and the surrogate endpoint problem, with application to vaccine trials

by Wolfson, Julian, Gilbert, Peter
Published 2010

Calibration Weighted Estimation of Semiparametric Transformation Models for Two-Phase Sampling

by Fong, Youyi, Gilbert, Peter
Published in Stat Med (2015)

Semiparametric estimation of the average causal effect of treatment on an outcome measured after a postrandomization event, with missing outcome data

by Gilbert, Peter B., Jin, Yuying
Published 2010

Increasing the Efficiency of Prevention Trials by Incorporating Baseline Covariates

by Zhang, Min, Gilbert, Peter B.
Published 2010

Estimation of Stratified Mark-Specific Proportional Hazards Models with Missing Marks

by Sun, Yanqing, Gilbert, Peter B.
Published 2012

Inferences on relative failure rates in stratified mark-specific proportional hazards models with missing marks, with application to HIV vaccine efficacy trials

by Gilbert, Peter B., Sun, Yanqing
Published in J R Stat Soc Ser C Appl Stat (2015)

Mark-Specific Hazard Ratio Model with Missing Multivariate Marks

by Juraska, Michal, Gilbert, Peter B.
Published in Lifetime Data Anal (2015)

Joint modeling of longitudinal and survival data with the Cox model and two-phase sampling

by Fu, Rong, Gilbert, Peter B.
Published in Lifetime Data Anal (2016)

Predicting Overall Vaccine Efficacy in a New Setting by Re-Calibrating Baseline Covariate and Intermediate Response Endpoint Effect Modifiers of Type-Specific Vaccine Efficacy

by Gilbert, Peter B., Huang, Ying
Published in Epidemiol Methods (2016)

Cytomegalovirus –The Quest for an Effective Vaccine in Transplant Recipients Continues

by Boeckh, Michael, Gilbert, Peter B.
Published in Lancet Haematol (2015)

Sieve analysis to understand how SARS-CoV-2 diversity can impact vaccine protection

by Rolland, Morgane, Gilbert, Peter B.
Published in PLoS Pathog (2021)

Potential Impact of Increased Use of Biocides in Consumer Products on Prevalence of Antibiotic Resistance

by Gilbert, Peter, McBain, Andrew J.
Published 2003

Evaluating Candidate Principal Surrogate Endpoints

by Gilbert, Peter B., Hudgens, Michael G.
Published 2008

Assessing Vaccine Effects in Repeated Low-Dose Challenge Experiments

by Hudgens, Michael G., Gilbert, Peter B.
Published 2009